Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Ocean Biomedical Inc (OCEAW)
Ocean Biomedical Inc (OCEAW) News

OCEAW

Ocean Biomedical (OCEAW)

Ocean Biomedical Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OCEAW

1

Date	Time	Source	Headline	Symbol	Company
05/30/2024	9:15AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCEAW	Ocean Biomedical Inc
05/14/2024	3:10PM	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:OCEAW	Ocean Biomedical Inc
05/25/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Addition to the Russell 2000® Index	NASDAQ:OCEAW	Ocean Biomedical Inc
05/23/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Award for Novel Cancer Immunotherapy Treatment, Granted for Prostate Cancer, Colon Cancer, Ovarian Cancer, Kidney Cancer, Breast Cancer, Glioblastoma, Melanoma, and Lung Cancer.	NASDAQ:OCEAW	Ocean Biomedical Inc
05/16/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical, Inc. Enters into a $25 Million Convertible Note Facility	NASDAQ:OCEAW	Ocean Biomedical Inc
05/01/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical (NASDAQ: OCEA) Announces 70% Increase in Price Target by EF Hutton from $10 to $17 on New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 Antibody	NASDAQ:OCEAW	Ocean Biomedical Inc
04/27/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical (NASDAQ: OCEA) Announces New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 Antibody	NASDAQ:OCEAW	Ocean Biomedical Inc
04/25/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical (NASDAQ: OCEA) on World Malaria Day Announces Sharing of New Malaria Vaccine Paradigm at PATH Malaria Research Retreat in Washington, DC, by Scientific Co-founder Dr. Jonathan Kurtis	NASDAQ:OCEAW	Ocean Biomedical Inc
04/20/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Breakthrough Pulmonary Fibrosis Treatments Issued to Scientific Co-founder Dr. Jack A. Elias.	NASDAQ:OCEAW	Ocean Biomedical Inc
04/17/2023	8:01AM	GlobeNewswire Inc.	$134 Million in Financial Backing for Innovative Research and IND Fillings Announced by Ocean Biomedical (NASDAQ: OCEA); Provides Latest Updates on Advancement of Platform, Novel Discoveries in Malaria, Pulmonary Fibrosis and Oncology	NASDAQ:OCEAW	Ocean Biomedical Inc
04/13/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Developing “Whole New Class” of Malaria Therapeutics Issued to Scientific Co-founder Dr. Jonathan Kurtis	NASDAQ:OCEAW	Ocean Biomedical Inc
04/06/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical (NASDAQ: OCEA) Will Target Pulmonary Fibrosis Discoveries as Novel Treatments of Hermansky-Pudlak Syndrome	NASDAQ:OCEAW	Ocean Biomedical Inc
03/21/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical (NASDAQ: OCEA) Details Novel Malaria Therapeutic Discoveries at the NIH Laboratory of Malaria Vaccinology and Immunology on PfGARP’s Potential as a Highly Effective Vaccine Target and Therapeutic Candidate to Treat Malaria	NASDAQ:OCEAW	Ocean Biomedical Inc
03/16/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by Fundamental Research Corp. with a “Buy” Recommendation	NASDAQ:OCEAW	Ocean Biomedical Inc
03/14/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by EF Hutton with a “Buy” Recommendation	NASDAQ:OCEAW	Ocean Biomedical Inc
03/09/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical (NASDAQ: OCEA) Shares Detailed Research Data on Anti-Tumor Pathway Discoveries and Their Potential for Treatment of Non-Small Cell Lung Cancer, Metastatic Melanoma, and Glioblastoma by Scientific Co-founder	NASDAQ:OCEAW	Ocean Biomedical Inc
02/28/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Award of New Patent to Scientific Co-Founder Dr. Jake Kurtis for Novel Malaria Vaccine Target	NASDAQ:OCEAW	Ocean Biomedical Inc
02/23/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical (NASDAQ: OCEA) Celebrates Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%	NASDAQ:OCEAW	Ocean Biomedical Inc
02/16/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical to Ring The Nasdaq Stock Market Opening Bell	NASDAQ:OCEAW	Ocean Biomedical Inc
02/15/2023	8:01AM	GlobeNewswire Inc.	Ocean Biomedical Debuts as Publicly Traded Company Focused on Accelerating the Commercialization of Innovative Assets from Research Universities and Medical Centers	NASDAQ:OCEAW	Ocean Biomedical Inc
02/09/2023	9:15AM	GlobeNewswire Inc.	Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce the Award of New Patents for Novel Monospecific and Bispecific Antibodies that Suppress Multiple Cancer Types	NASDAQ:OCEAW	Ocean Biomedical Inc
01/30/2023	9:15AM	GlobeNewswire Inc.	Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce Publication of Discovery Data for a Major Anti-Tumor Pathway in Malignant Melanoma and Other Cancers	NASDAQ:OCEAW	Ocean Biomedical Inc
01/24/2023	9:15AM	GlobeNewswire Inc.	Ocean Biomedical Provides Corporate Update and Company Summary	NASDAQ:OCEAW	Ocean Biomedical Inc
10/05/2022	7:45AM	GlobeNewswire Inc.	Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce Execution of a Second up to $40 Million Backstop Agreement, for a Total of up to $80 Million	NASDAQ:OCEAW	Ocean Biomedical Inc
08/31/2022	7:47AM	GlobeNewswire Inc.	Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ	NASDAQ:OCEAW	Ocean Biomedical Inc

Showing the most relevant articles for your search:NASDAQ:OCEAW

1

Faraday Future Intellige...

Rennova Health (PK)

Ubiquitech Software (PK)

Ronn Motor (PK)

Fannie Mae (QB)

Intergrated Cannabis Sol... (PK)

Decentral Life (PK)

Branded Legacy (PK)

Enzolytics (PK)

Digital Brand Media and ... (PK)

TPT Global Tech (PK)

Marketing Worldwide (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions